Search results
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 5 days agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Why Are Xeris Biopharma Shares Moving Monday? - Xeris Biopharma Holdings (NASDAQ:XERS)
Benzinga· 13 hours agoXeris Biopharma Holdings, Inc XERS shares are up Monday after the company announced an exclusive...
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoGenmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 6 days agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
Morning Brew: Tesla's Innovative Patent Sparks Investor Interest
Guru Focus· 16 hours agoStock market futures are showing optimism this morning, with S&P 500 futures up by 18 points (0.3%),...
Wall Street Looks To Extend Rally Amid Caution Over Fed Speeches, More Earnings: Why This Analyst...
Benzinga· 18 hours agoU.S. stocks are likely to extend their gains as major index futures are modestly higher on Monday....
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 3 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has been fighting a class-action ...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 5 days ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 6 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 5 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...